MAA
BPMC

Mraz Amerine & Associates’s Blueprint Medicines BPMC Stock Holding History

Mraz Amerine & Associates’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,391
Closed -$478K – 192
2025
Q1 		$478K Buy
5,391
+45
+0.8% +$4.39K 0.08% 112
2024
Q4 		$466K Sell
5,346
-435
-8% -$39.8K 0.08% 111
2024
Q3 		$535K Sell
5,781
-167
-3% -$16.6K 0.1% 111
2024
Q2 		$641K Sell
5,948
-128
-2% -$12.8K 0.13% 103
2024
Q1 		$576K Sell
6,076
-235
-4% -$20.2K 0.11% 108
2023
Q4 		$582K Hold
6,311
– – 0.12% 105
2023
Q3 		$317K Sell
6,311
-260
-4% -$13.9K 0.07% 134
2023
Q2 		$415K Hold
6,571
– – 0.1% 117
2023
Q1 		$296K Buy
+6,571
New +$296K 0.07% 133

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return